TransMedics (TMDX) FCF Margin Growth (1y) (2019 - 2026)
TransMedics (TMDX) FCF Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 194.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 66.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 119.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 1,788.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | -395.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 112.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -505.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | -473.00 |
| 10 | TransMedics | 3.18 Bn | 2.71 Bn | 113.20 Mn | -4,707.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4,707.00 |
| Mar 31, 2026 | 1,386.00 |
| Dec 31, 2025 | -9,972.00 |
| Sep 30, 2025 | 11,842.00 |
| Jun 30, 2025 | 1,427.00 |
| Mar 31, 2025 | 2,833.00 |
| Dec 31, 2024 | 28,830.00 |
| Sep 30, 2024 | -9,014.00 |
| Jun 30, 2024 | 7,055.00 |
| Mar 31, 2024 | -2,608.00 |
| Dec 31, 2023 | -15,510.00 |
| Sep 30, 2023 | 7,573.00 |
| Jun 30, 2023 | 3,678.00 |
| Mar 31, 2023 | 9,875.00 |
| Dec 31, 2022 | 9,331.00 |
| Sep 30, 2022 | 8,936.00 |
| Jun 30, 2022 | 2,074.00 |
| Mar 31, 2022 | -2,575.00 |
| Dec 31, 2021 | -1,577.00 |
| Sep 30, 2021 | -9,524.00 |